ContraFect Corporation Profile Avatar - Palmy Investing

ContraFect Corporation

ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes …

Biotechnology
US, Yonkers [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CFRX's Analysis
CIK: 1478069 CUSIP: 212326300 ISIN: US2123264093 LEI: - UEI: -
Secondary Listings
CFRX has no secondary listings inside our databases.